PBYI
Puma Biotechnology, Inc.
9.60$
+0.8%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 20.2% | 13.8% | 13.5% | 17.5% | 25.2% | 24.2% | 26.6% | 27.9% | 25.5% | |
| – | – | – | 79.8% | 86.2% | 86.5% | 82.5% | 74.8% | 75.8% | 73.4% | 72.1% | 74.5% | |
| – | – | – | 750.2% | 65.7% | 48.8% | 43.4% | 28.4% | 22.9% | 21.4% | 23.8% | 27.2% | |
| – | – | – | 385.2% | 58.2% | 51.6% | 52.6% | 45.9% | 39.5% | 37.5% | 35.0% | 31.2% | |
| – | – | – | 1,135.4% | 123.9% | 114.2% | 96.0% | 74.3% | 65.4% | 59.5% | 58.6% | 58.2% | |
| – | – | – | -1,055.6% | -37.7% | -27.8% | -13.5% | 0.5% | 10.4% | 13.9% | 13.4% | 16.3% | |
| – | – | – | 2.6% | 4.4% | 5.5% | 6.2% | 5.1% | 5.1% | 5.7% | 5.4% | 2.9% | |
| – | – | – | -1,054.2% | -45.3% | -27.7% | -26.6% | -11.4% | 0.2% | 9.6% | 10.5% | 15.7% | |
| – | – | – | -8.0% | -3.2% | 0.0% | 0.1% | 0.1% | 0.2% | 0.5% | -2.7% | 2.0% | |
| – | – | – | -1,054.2% | -45.3% | -27.8% | -26.7% | -11.5% | 0.0% | 9.2% | 13.1% | 13.6% | |
| – | – | – | -1,041.2% | -37.9% | -19.3% | -15.9% | -1.9% | 9.6% | 20.2% | 20.9% | 23.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.